1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Liver Neoplasms
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Liver Neoplasms in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, L; Chen, MH; He, Q; Jumai, N; Lin, Y; Liu, M; Luo, Y; Wang, Y; Zeng, Z; Zhang, N; Zhang, X | 1 |
Chen, X; Deng, H; Huang, Y; Ou, L; Song, Y; Wang, Y; Zhou, Y | 1 |
Cha, S; Ehman, EC; Hope, TA; Johnson, GB; Larson, PEZ; Leynes, AP; Villanueva-Meyer, JE | 1 |
Jin, Y; Tian, J; Wang, K | 1 |
Roesch, F | 1 |
Baum, RP; Müller, D; Senftleben, S; Wehrmann, C; Zachert, C | 1 |
Reviews
1 review(s) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Liver Neoplasms
Article | Year |
---|---|
PET/MRI: Where might it replace PET/CT?
Topics: Adult; Aged; Cohort Studies; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Infections; Inflammation; Liver Neoplasms; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Motion; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology; Reproducibility of Results | 2017 |
Other Studies
5 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Liver Neoplasms
Article | Year |
---|---|
The role of quantitative tumor burden based on [
Topics: Humans; Ki-67 Antigen; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Somatostatin; Tumor Burden | 2023 |
[
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2023 |
Preoperative Examination and Intraoperative Identification of Hepatocellular Carcinoma Using a Targeted Bimodal Imaging Probe.
Topics: Animals; Carcinoma, Hepatocellular; Coloring Agents; Contrast Media; Gadolinium; Hep G2 Cells; Heterocyclic Compounds, 1-Ring; Humans; Infrared Rays; Liver Neoplasms; Magnetic Resonance Imaging; Mice, Inbred BALB C; Mice, Nude; Optical Imaging; Peptides; Preoperative Period | 2018 |
Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator system.
Topics: Adsorption; Animals; Cation Exchange Resins; Chelating Agents; Drug Stability; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental; Nickel; Nuclear Reactors; Positron-Emission Tomography; Puromycin; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals; Scandium; Titanium; Transplantation, Heterologous | 2012 |
Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC.
Topics: Adult; Aged; Bone Neoplasms; Female; Heterocyclic Compounds, 1-Ring; Humans; Liver Neoplasms; Lutetium; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Receptors, Peptide; Tomography, X-Ray Computed | 2007 |